A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke

Overview of attention for article published in Science Translational Medicine, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 30 X users

wikipedia: 1 Wikipedia page
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user

Readers on

mendeley: 51 Mendeley

So far, Altmetric has seen 33 X posts from 30 X users, with an upper bound of 1,357,424 followers.

2020〜2022年に行った最初の試験であるSPAN1では尿酸が有効性を示し、その後の再解析ではファスジル、フィンゴリモドなども有効性が確認されました。今回、SPAN1で有効性を示した尿酸も有効域に達しなかったことも興味深いです(以前のプロトコールとの差異はあります) htt…

Most drugs fail to transition from preclinical research to human patients. A @sciencemagazine article reveals results from a multi-lab, standardized, randomized, and blinded preclinical trial testing 6 stroke treatment candidates. https://t.co/geAk9GgT…

RT @SepsisCanada: Join the @sepsiscanada NPSP Journal Club tomorrow, where they present Dr. Lyden's “A multi-laboratory preclinical trial i…

Join the @sepsiscanada NPSP Journal Club tomorrow, where they present Dr. Lyden's “A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke” https://t.co/NdHEkvq99T Contact [email protected]">@ohri.ca">[email protected] for the meet…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 29 additional X posts.